Haven't had much time lately? Here's what you may have missed in the last few months
The ESMO Tumour Portals allow you to find the key educational resources in your field of interest
17 Dec 2014
Entecavir significantly reduces the risk of hepatitis B virus reactivation and hepatitis in lymphoma patients undergoing chemotherapy compared with...
16 Dec 2014
A multikinase inhibitor plus mammalian target of rapamycin inhibitor regimen may offer limited progression-free survival benefit for patients with...
16 Dec 2014
New module by Michael Stahl out now. View the presentation and, if you are an ESMO member, take the CME test!
15 Dec 2014
Fulvestrant may improve overall survival in patients with advanced, hormone receptor-positive breast cancer compared with anastrozole
ESMO V-Learning: P. Bedard discusses interpatient heterogeneity, elaborates sequencing platforms and considerations for clinical testing in cancer patients, as well as already launched clinical personalised medicine programmes. He covers genomic assessment of intrapatient tumour heterogeneity and challenges posed for personalised medicine.